Literature DB >> 18317227

Histologic subtypes of ovarian carcinoma: an overview.

Robert A Soslow1.   

Abstract

Reproducible subclassification of ovarian carcinomas is biologically and increasingly therapeutically important. The traditional morphologic approach that ignores genotype and immunophenotype is subjective and therefore suboptimal. This review covers the prevalence, morphology, immunophenotype and, in some cases, genotype of each major ovarian cancer subtype. Serous carcinomas, frequently WT1 positive, are morphologically diverse and mimic other tumors. Most transitional cell carcinomas are closely related to them. Mucinous carcinomas are uncommon and should only be diagnosed after extraovarian primaries are excluded; true ovarian mucinous carcinomas are usually low stage. Intestinal and mullerian mucinous (seromucinous) tumors are histogenetically and clinically distinct. Ovarian endometrioid carcinomas almost always resemble endometrioid carcinomas of endometrium, express estrogen receptors (ER) but not WT1, and are frequently low grade and low stage. Ovarian clear cell carcinomas, negative for ER and WT1 and lacking p53 overexpression, have a limited morphologic repertoire and are frequently low stage at presentation. Clinical biology, immunohistochemistry, and genotype can be used to enhance diagnostic objectivity.

Entities:  

Mesh:

Year:  2008        PMID: 18317227     DOI: 10.1097/PGP.0b013e31815ea812

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  94 in total

1.  Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.

Authors:  Thapi Dharma Rao; Kay J Park; Peter Smith-Jones; Alexia Iasonos; Irina Linkov; Robert A Soslow; David R Spriggs
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-10

Review 2.  Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting.

Authors:  Antonio González-Martín; Gemma Toledo; Luis Chiva
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

3.  A multivariate model of ErbB network composition predicts ovarian cancer cell response to canertinib.

Authors:  Rexxi D Prasasya; Kang Z Vang; Pamela K Kreeger
Journal:  Biotechnol Bioeng       Date:  2011-08-23       Impact factor: 4.530

4.  Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.

Authors:  Martin Köbel; Steve E Kalloger; Sandra Lee; Máire A Duggan; Linda E Kelemen; Leah Prentice; Kimberly R Kalli; Brooke L Fridley; Daniel W Visscher; Gary L Keeney; Robert A Vierkant; Julie M Cunningham; Christine Chow; Roberta B Ness; Kirsten Moysich; Robert Edwards; Francesmary Modugno; Clareann Bunker; Eva L Wozniak; Elizabeth Benjamin; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; C Blake Gilks; David G Huntsman; Susan J Ramus; Ellen L Goode
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-23       Impact factor: 4.254

5.  Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.

Authors:  Nicholas Veomett; Tao Dao; Hong Liu; Jingyi Xiang; Dmitry Pankov; Leonid Dubrovsky; Joseph A Whitten; Sun-Mi Park; Tatyana Korontsvit; Victoria Zakhaleva; Emily Casey; Michael Curcio; Michael G Kharas; Richard J O'Reilly; Cheng Liu; David A Scheinberg
Journal:  Clin Cancer Res       Date:  2014-05-21       Impact factor: 12.531

Review 6.  [Morphology of secondary ovarian tumors and metastases].

Authors:  L-C Horn; J Einenkel; R Handzel; A K Höhn
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

7.  Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.

Authors:  Pradeep S Tanwar; Gayatry Mohapatra; Sarah Chiang; David A Engler; Lihua Zhang; Tomoko Kaneko-Tarui; Yasuyo Ohguchi; Michael J Birrer; Jose M Teixeira
Journal:  Carcinogenesis       Date:  2013-10-29       Impact factor: 4.944

8.  Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.

Authors:  Guoqing Cai; Xiangdong Ma; Biliang Chen; Yanhong Huang; Shujuan Liu; Hong Yang; Wei Zou
Journal:  Tumour Biol       Date:  2016-04-08

9.  Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.

Authors:  Yi-Jen Chen; Chun-Ming Chen; Nae-Fang Twu; Ming-Shyen Yen; Chiung-Ru Lai; Hua-Hsi Wu; Peng-Hui Wang; Chiou-Chung Yuan
Journal:  Virchows Arch       Date:  2009-10-17       Impact factor: 4.064

10.  Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes.

Authors:  Yaser R Hussein; Jennifer A Ducie; Angela G Arnold; Noah D Kauff; Hebert A Vargas-Alvarez; Evis Sala; Douglas A Levine; Robert A Soslow
Journal:  Am J Surg Pathol       Date:  2016-03       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.